Assignee
BECKLEY PSYTECH LTD
GB·12 granted patents·6 pending applications·24 citations·filing 2022–2025
Top patents by PatentIndex Score
18 records- 0195US11980605B15-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) formulationsBECKLEY PSYTECH LTD·Filed 2023·Granted May 14, 2024·3 cites·16 claims
- 0294US11518743B2Pharmaceutical composition comprising 5-methoxy-N,N-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2022·Granted Dec 6, 2022·4 cites·16 claims
- 0394US11518742B2Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2022·Granted Dec 6, 2022·4 cites·14 claims
- 0493US11773063B1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2022·Granted Oct 3, 2023·7 cites·10 claims
- 0589US11697651B2Ergoline analoguesBECKLEY PSYTECH LTD·Filed 2022·Granted Jul 11, 2023·6 cites·7 claims
- 0679US11603353B2Composition comprising a benzoate salt of 5-methoxy-N,N-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2022·Granted Mar 14, 2023·0 cites·15 claims
- 0777US12246005B25-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulationsBECKLEY PSYTECH LTD·Filed 2024·Granted Mar 11, 2025·0 cites·20 claims
- 0877US11680044B2Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2022·Granted Jun 20, 2023·0 cites·19 claims
- 0977US2023382858A1Pharmaceutical composition comprising 5-methoxy-n,n-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2023·Application pending·0 cites
- 1076US12275735B2Ergoline analoguesBECKLEY PSYTECH LTD·Filed 2023·Granted Apr 15, 2025·0 cites·20 claims
- 1176US2023348381A1Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamineBECKLEY PSYTECH LTD·Filed 2023·Application pending·0 cites
- 1272US2026035334A1Method of synthesisBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1371US11787806B2Ergoline analoguesBECKLEY PSYTECH LTD·Filed 2022·Granted Oct 17, 2023·0 cites·18 claims
- 1469US12264131B2Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 1566US2025263372A1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1665US2026041667A1Prescription digital therapeuticsBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1749US2025193970A15-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) FORMULATIONSBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1848US12534441B2Tryptamine analoguesBECKLEY PSYTECH LTD·Filed 2022·Granted Jan 27, 2026·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →